Portland Global Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.03M Buy
24,945
+47
+0.2% +$16.1K 0.86% 34
2026
Q1
$8.76M Buy
24,898
+167
+0.7% +$59.5K 0.93% 33
2025
Q4
$8.09M Buy
24,731
+666
+3% +$211K 0.87% 35
2025
Q3
$6.79M Buy
24,065
+287
+1% +$83.2K 0.76% 37
2025
Q2
$6.64M Sell
23,778
-98
-0.4% -$27.8K 0.78% 35
2025
Q1
$7.44M Buy
23,876
+121
+0.5% +$35.7K 0.94% 31
2024
Q4
$6.19M Buy
23,755
+205
+0.9% +$60.8K 0.78% 36
2024
Q3
$7.59M Buy
23,550
+397
+2% +$130K 0.95% 31
2024
Q2
$7.23M Buy
23,153
+204
+0.9% +$59.9K 0.98% 29
2024
Q1
$6.52M Sell
22,949
-297
-1% -$86.9K 0.89% 33
2023
Q4
$6.7M Buy
23,246
+180
+0.8% +$49K 1% 29
2023
Q3
$6.2M Buy
23,066
+425
+2% +$106K 1.04% 28
2023
Q2
$5.03M Buy
22,641
+960
+4% +$223K 0.82% 36
2023
Q1
$5.24M Buy
21,681
+1,204
+6% +$296K 0.9% 34
2022
Q4
$5.38M Sell
20,477
-1,068
-5% -$286K 0.99% 31
2022
Q3
$4.86M Buy
21,545
+33
+0.2% +$8K 0.97% 30
2022
Q2
$5.23M Buy
21,512
+244
+1% +$59.8K 1% 26
2022
Q1
$5.14M Buy
21,268
+741
+4% +$170K 0.88% 31
2021
Q4
$4.62M Buy
20,527
+1,342
+7% +$283K 0.77% 35
2021
Q3
$4.08M Buy
19,185
+1,187
+7% +$273K 0.75% 37
2021
Q2
$4.39M Buy
17,998
+668
+4% +$164K 0.85% 34
2021
Q1
$4.31M Buy
17,330
+191
+1% +$45.6K 0.92% 32
2020
Q4
$3.94M Buy
17,139
+125
+0.7% +$28.8K 0.96% 25
2020
Q3
$4.32M Sell
17,014
-220
-1% -$54.5K 1.25% 19
2020
Q2
$4.07M Buy
17,234
+80
+0.5% +$18.3K 1.31% 17
2020
Q1
$3.48M Sell
17,154
-734
-4% -$160K 1.35% 15
2019
Q4
$4.31M Sell
17,888
-379
-2% -$83.5K 1.28% 16
2019
Q3
$3.54M Buy
18,267
+75
+0.4% +$14.4K 1.18% 19
2019
Q2
$3.35M Buy
18,192
+3,133
+21% +$561K 1.12% 20
2019
Q1
$2.86M Buy
15,059
+122
+0.8% +$23.3K 1% 24
2018
Q4
$2.91M Buy
14,937
+283
+2% +$55.2K 1.17% 21
2018
Q3
$3.04M Buy
14,654
+27
+0.2% +$5.32K 1.07% 22
2018
Q2
$2.7M Buy
14,627
+206
+1% +$36.4K 1.02% 23
2018
Q1
$2.46M Sell
14,421
-339
-2% -$62.2K 0.94% 24
2017
Q4
$2.57M Sell
14,760
-210
-1% -$37.2K 0.95% 23
2017
Q3
$2.79M Sell
14,970
-101
-0.7% -$17.9K 1.07% 20
2017
Q2
$2.6M Buy
15,071
+45
+0.3% +$7.32K 1.04% 20
2017
Q1
$2.46M Sell
15,026
-345
-2% -$57.3K 1.03% 23
2016
Q4
$2.25M Buy
15,371
+562
+4% +$84.6K 0.98% 24
2016
Q3
$2.47M Buy
14,809
+115
+0.8% +$19.4K 1.09% 20
2016
Q2
$2.24M Buy
14,694
+32
+0.2% +$4.97K 1.02% 24
2016
Q1
$2.2M Buy
14,662
+588
+4% +$87.4K 1.05% 20
2015
Q4
$2.29M Buy
14,074
+620
+5% +$97.5K 1.23% 17
2015
Q3
$1.86M Sell
13,454
-545
-4% -$85.9K 1.1% 23
2015
Q2
$2.15M Sell
13,999
-100
-0.7% -$16K 1.12% 21
2015
Q1
$2.25M Sell
14,099
-260
-2% -$40.9K 1.16% 16
2014
Q4
$2.29M Buy
14,359
+94
+0.7% +$14.6K 1.18% 14
2014
Q3
$2M Sell
14,265
-245
-2% -$32K 1.04% 20
2014
Q2
$1.72M Buy
14,510
+1,488
+11% +$172K 0.86% 32
2014
Q1
$1.61M Buy
13,022
+185
+1% +$22.4K 0.95% 29
2013
Q4
$1.46M Sell
12,837
-525
-4% -$59.7K 0.91% 30
2013
Q3
$1.5M Sell
13,362
-270
-2% -$29.3K 1.01% 24
2013
Q2
$1.34M Buy
+13,632
New +$1.41M 0.96% 28

Other funds holding AMGN

Portland Global Advisors's AMGN Position: Q2 2026 in Review

Portland Global Advisors increased its Amgen (AMGN) stake by 0.19% in Q2 2026, buying an estimated $16.1K and bringing the position to 24,945 shares worth $9.03M. The position accounts for 0.86% of the portfolio, ranked #34.

Portland Global Advisors first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Portland Global Advisors held 24,945 shares of Amgen worth $9.03M as of Q2 2026.
  • Portland Global Advisors bought 47 Amgen shares in Q2 2026, an estimated $16.1K.
  • Amgen made up 0.86% of Portland Global Advisors's portfolio in Q2 2026, its #34 holding.
  • Portland Global Advisors first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Portland Global Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.